Center-Authored Papers

Filters: Author is Hill, Deirdre A  [Clear All Filters]
2008
Morton LM, Wang SS, Cozen W, Linet MS, Chatterjee N, Davis S, Severson RK, Colt JS, Vasef MA, Rothman N et al..  2008.  Etiologic heterogeneity among non-Hodgkin lymphoma subtypes.. Blood. 112(13):5150-60. Abstract
Saltzman BS, Doherty JA, Hill DA, Beresford SAA, Voigt LF, Chen C, Weiss NS.  2008.  Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors.. American journal of epidemiology. 167(5):607-14. Abstract
2011
Phipps AI, Doherty JA, Voigt LF, Hill DA, Beresford SAA, Rossing MA, Chen C, Weiss NS.  2011.  Long-term use of continuous-combined estrogen-progestin hormone therapy and risk of endometrial cancer.. Cancer causes & control : CCC. 22(12):1639-46. Abstract
Pocobelli G, Doherty JA, Voigt LF, Beresford SAA, Hill DA, Chen C, Rossing MA, Holmes RS, Noor ZS, Weiss NS.  2011.  Pregnancy history and risk of endometrial cancer.. Epidemiology (Cambridge, Mass.). 22(5):638-45. Abstract
2014
Lowery JT, Horick N, Kinney AY, Finkelstein DM, Garrett K, Haile RW, Lindor NM, Newcomb PA, Sandler RS, Burke CA et al..  2014.  A randomized trial to increase colonoscopy screening in members of high risk families in the Colorectal Cancer Family Registry and Cancer Genetics Network.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
2015
Lee CI, Bogart A, Hubbard RA, Obadina ET, Hill DA, Haas JS, Tosteson ANA, Alford-Teaster JA, Sprague BL, DeMartini WB et al..  2015.  Advanced Breast Imaging Availability by Screening Facility Characteristics.. Academic radiology. Abstract
Lee CI, Bogart A, Germino JC, Goldman EL, Hubbard RA, Haas JS, Hill DA, Tosteson ANA, Alford-Teaster JA, DeMartini WB et al..  2015.  Availability of Advanced Breast Imaging at Screening Facilities Serving Vulnerable Populations.. Journal of medical screening. Abstract
2016
Chen L, Cook LS, Tang M-TC, Porter PL, Hill DA, Wiggins CL, Li CI.  2016.  Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer.. Breast cancer research and treatment. 157(3):545-54. Abstract
Chen L, Li CI, Tang M-TC, Porter P, Hill DA, Wiggins CL, Cook LS.  2016.  Reproductive factors and risk of luminal, HER2-overexpressing and triple negative breast cancer among multiethnic women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract